Brief: Cereno Scientific: Positive Results From Study With CS1
28/06/2018 10:39
June 28 (Reuters) - Cereno Scientific AB CRNOSb.TE :
* CERENO SCIENTIFIC PRESENTS POSITIVE RESULTS FROM THE FIRST
CLINICAL STUDY WITH CS1
* CERENO SCIENTIFIC - FIRST CLINICAL STUDY CONCLUDED WITH
POSITIVE
RESULTS REGARDING SAFETY, PHARMACOKINETIC PROPERTIES AND EFFECT
ON BIOMARKER FOR RISK OF THROMBOSIS
Source text for Eikon: ID:nWkr56j32c
Further company coverage: CRNOSb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global